Our Phage Picks for June 2024!

Issue 269 | June 14, 2024
12 min read
Capsid and Tail

It’s Phage Picks time! This week we’ve got the fourth rendition of our new format (and Jan’s favourite…!) where we share the papers we keep bookmarked, and keep coming back to.

(Yes, Jan now reads more phage papers than Jessica, and she’s very insecure about it…)

What’s New

HYpharm GmbH and the German Center for Infection Research announced that their phage lysin HY-133 has entered phase I clinical trials. HY-133 aims to prevent nasal colonization by MRSA. The trial is conducted at the University Hospital of Tübingen to test the safety and toxicity of HY-133 in healthy volunteers.

Biotech newsClinical TrialPhage therapy

Deepto Mozumdar (University of California, San Francisco) and colleagues have characterized a new lipid-based jumbo phage compartment — a hub for early phage infection. The study explores how phage ΦKZ assembles a vesicle to protect its genome from host defenses during early infection of P. aeruginosa, facilitating genome protection, transcription, and transfer to the phage nucleus.

Jumbo phagePhage organellesResearch paper

Khalimat Murtazalieva (European Bioinformatics Institute) and colleagues have discovered 145 phage anti-defence systems (ADSs) that counteract 27 of the 152 known bacterial defence families. They discuss high-throughput approaches which are indispensable for discovering new ADSs.

Anti-defense systemsComputational biologyResearch paper

Beatriz Beamud (Institut Pasteur) and colleagues have discovered that many bacterial defense systems against phages are encoded by mobile genetic elements, challenging traditional views of bacterial immunity.

Mobile genetic elementsBacterial immunityResearch paper

In a new preprint, Ritam Das and Janina Rahlff (Friedrich Schiller University Jena, Germany) describe a positive correlation between the number of structural genes and above-average guanine-cytosine (GC) content in phage genomes.

PreprintBioinformaticsGenome annotation

Latest Jobs

Gut PhageomesWild Primate SamplesSub Saharan Africa
Jan Gogarten from the Helmholtz Institute for One Health is seeking a postdoc to study gut phageomes of primates, including exploring a sample set of over 120,000 wild primate samples across Sub Saharan Africa.
Elena Gómez-Sanz (University of Bern, Switzerland) is hiring 1) a postdoc in phages and AMR to develop strategies to visualize transduction dynamics; 2) a PhD student to characterize a unique staphylococcal phage-host library to assess and measure transduction and to select phage candidates with potential translational applications; and 3) a PhD student to measure contribution of staphylococcal temperate phages to bacterial adaptation to antibiotics.
RNAWastewaterPost Doc
If you are or know a freshly graduated PhD looking for a postdoc, and interested in RNA phage discovery or wastewater phages, come (or send them) my way! We have a few collaborative projects with positions available right now! — Simon Roux, via Twitter
Biologics PurificationBiotechDevelopment Scientist
Locus Biosciences (Morrisville, North Carolina) is hiring a Development Scientist to be responsible for developing biologics purification processes and formulations, serving as a subject matter expert and lead scientist in partner relationships, and leading early phase clinical trial material manufacturing in an aseptic processing environment.
Post BacVancomycin-Resistant EnterococciPhage therapy
The FDA’s Oak Ridge Institute for Science and Education is hiring a Postbac Fellow to develop and characterize phage therapy for decolonizing Vancomycin-Resistant Enterococci.
Senior Research AssistantResearch FellowPhage biology
The University of Hertfordshire, Hatfield, UK is hiring a Senior Research Assistant / Research Fellow to take responsibility for a phage research stream, contribute to other research activities, and help with student projects.
Research AssociatePhage display
Avail Bio (San Francisco) is hiring a Research Associate, Phage Display to support target discovery efforts.
High-Throughput ScreeningBiotechScientist
Xaira Therapeutics (Seattle, USA) is hiring a Scientist, Phage High-Throughput Screening with prior experience in library building, cloning, DNA manipulation, and phage display screening/sorting with antibody or protein libraries for therapeutic discovery.

Community Board

Anyone can post a message to the phage community — and it could be anything from collaboration requests, post-doc searches, sequencing help — just ask!

New phage conference alert — this time in South America!!

Phage researchers at the Universidad de los Andes invite the international phage community to Phage Option Congress 2024 (Dec 4-6, 2024 in Cartagena, Colombia).

This will be the 3rd Latin American Meeting on Bacteriophages, and will span phage biology and applications across human, animal and plant health.

Speakers include Sandro Sulakvelidze (Intralytix), Mikeljon Nikolich (Walter Reed Army Institute of Research), Sofia Corte-Real (Technophage), Frenk Smrekar (Jafral), Krystyna Dabrowska (Polish Academy of Sciences), and more to be announced!

Organizers include Alejandro Reyes, Mariana Piuri, Martha Vives, Santiago Hernandez, Viviana Clavijo, and Sandra Morales.

Register here.

ConferenceLatin AmericaPhage biologyPhage applications

Registration is now open for the 2024 International Soil Virus Conference!

Soil virologists and enthusiasts will gather to explore the multifaceted roles of soil viruses within a One Health framework, with a special focus on meta-omics characterization of soil viruses and their connections with biogeochemistry, food web dynamics, and soil health.

The meeting takes place June 25 to June 27 at the University of California Livermore Collaboration Center (virtual option available).

Register by June 14!

Soil virusesMeta-omicsConference

Lina Zeldovich, an author who grew up in a family of Soviet scientists, published a new book, ‘The Living Medicine: How a Lifesaving Cure Was Nearly Lost—and Why It Will Rescue Us When Antibiotics Fail’. She explores the history and potential of phages, tracing the journey of phage therapy from its discovery to its near extinction and current revival.

Steffanie Strathdee read the book and tweeted “If you thought you knew everything about #phagetherapy, you were wrong!”.

BookPhage historyPhage therapy

Our Phage Picks for June 2024!

Profile Image
Product designer and co-founder of Phage Directory
Co-founderProduct Designer
Twitter @yawnxyz
Skills

Bioinformatics, Data Science, UX Design, Full-stack Engineering

I am a co-founder of Phage Directory, and have a Master of Human-Computer Interaction degree from Carnegie Mellon University and a computer science and psychology background from UMBC.

For Phage Directory, I design and build tools, and help write and organize Capsid & Tail.

I’ve previously worked at the Westmead Institute, for the Iredell lab at Phage Australia. There, I helped connect bioinformatics outputs and databases like REDCap, Google Drive, and S3-compatible storage systems.

Currently, I’m building and designing AI-centric tools for biology, including experimenting with protein models, biobank databases, AI-supported schema and data parsing, and bioinformatics workflows. Hit me up at [email protected] if you’re curious to collaborate!

Hi everyone,

It’s time for another Phage Picks, a new monthly format for highlighting our favorite papers.

If we missed a cool or important paper — email us to let us know: [email protected].

Nanopore and Illumina sequencing reveal different viral populations from human gut samples

What is it about?

Evelien’s team compared Illumina’s short-read sequencing against ONT’s long-read sequencing, and various assembly strategies for getting phage genomes from fecal samples. It turns out that Illumina is generally better for recovering fully resolved viral genomes, while ONT is better for capturing broader viral diversity. The paper then discusses using hybrid approaches to get more authentic representations of viral diversity.

From Evelien’s tweet: “Sequencing platform, assembler, binning tools all recover different viral populations and have their pros and cons, choose wisely based on your research question.”

Why I’m excited about it:

Aside from the findings, the papers goes quite deeply into mixing, matching, and using various assembly and binning tools.

This is the kind of paper that might be very useful for “saving for later” if you ever find yourself in the depths of figuring out “when and how should I use Illumina vs. ONT… with which tools, and using what settings and configurations?”

~ Jan

Access: https://doi.org/10.1099/mgen.0.001236

Cook, R., Telatin, A., Hsieh, S., Newberry, F., Tariq, M. A., Baker, D. J., Carding, S. R., & Adriaenssens, E. M. (2024). Nanopore and Illumina sequencing reveal different viral populations from human gut samples. Microbial Genomics10(4). https://doi.org/10.1099/mgen.0.001236


Prediction of Klebsiella phage-host specificity at the strain level

What is it about?

The authors built a predictive machine learning model for Klebsiella phage-host infectivity. They used a combination of ESM-2 protein language model for creating “vector” representations of receptor-binding proteins and Klebsiella-specific capsule polysaccharides called K-antigens. They then created an XGBoost model for predicting if a provided pair of phages and bacteria can lead to infectivity.

Why I’m excited about it:

I love how this paper spells out how machine learning can be used predict to phage-host infectivity. The authors go into lengths to both share the data and explain / document the code. The code is fully documented, and even includes an easy to use, step by step Jupyter Notebook to help readers replicate their results.

Though the model is very specific to RBPs and K-antigens, the paper and accompanying code acts like a tutorial for other labs to follow suit and build their own models predictive.

I love clearly the laid out all the steps and all the code — and anyone with a M1 Macbook (or faster) can reproduce all the results, and even make their own (Klebsiella strain) phage-host predictions with the accompanying notebook.

Overall, it’ll hopefully help others create more diagnostic tools across all of the ESKAPE pathogens that severely cut down the time it takes to find suitable phages.

~ Jan

Twitter thread: https://twitter.com/dimiboeckaerts/status/1793321221846880599

Paper: https://doi.org/10.1038/s41467-024-48675-6

Github: https://github.com/dimiboeckaerts/PhageHostLearn

Data: https://zenodo.org/records/11061100

Boeckaerts, D., Stock, M., Ferriol-González, C., Oteo-Iglesias, J., Sanjuán, R., Domingo-Calap, P., De Baets, B., & Briers, Y. (2024). Prediction of Klebsiella phage-host specificity at the strain level. In Nature Communications (Vol. 15, Issue 1). Springer Science and Business Media LLC. https://doi.org/10.1038/s41467-024-48675-6


Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii

What is it about?

The authors isolated two phages — LemonAid and Tonic — that can infect drug-resistant A. baumannii. They also discovered that the A. baumannii developed resistance to these phages at the cost to virulence, correlated with a gene potentially affection a phage receptor.

Why I’m excited about it:

These phage resistance / virulence / antibiotic resistance tradeoff papers are super interesting to me. These kinds of papers show that we can potentially drive phages to “evolve” in certain directions by giving up certain characteristics, like virulence. Similar to Yale’s efflux pump-affecting phage, OMKO-1, it shows that we need to be collecting phages based on how we know the phage will affect the bacterial target (whether it’s through lysis or merely driving it to evolve in a certain way, leading it to an evolutionary trap where we can then kill it with antibiotics). The paper also highlights the necessity to discover and document more phage-host interactions that change either the phage or host characteristics.

~ Jan

Paper: https://doi.org/10.1099/jmm.0.001829

Manley, R., Fitch, C., Francis, V., Temperton, I., Turner, D., Fletcher, J., Phil, M., Michell, S., & Temperton, B. (2024). Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii. In Journal of Medical Microbiology (Vol. 73, Issue 5). Microbiology Society. https://doi.org/10.1099/jmm.0.001829


Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny

What is it about?

The author of this paper discovered that various antibiotics can induce lysis from otherwise temperate phages. Surprisingly, some of the antibiotics that worked were not traditionally known to induce an “SOS” response. A novel protein synthesis inhibitor mechanism seems to be the culprit behind this antibiotic-phage synergy behavior.

Why I’m excited about it:

It seems like there are so many more mechanisms and relationships out there we don’t know about, between phages, bacteria, and antibiotics. This paper highlights the need to check how antibiotics will affect lysis (including temperate phages), the necessity to identify the mechanisms, and the need to systematically collect data, even in situations where “we obviously know it won’t work” — because we actually know so little about these phage / host / antibiotic interactions.

It also highlights the need for more larger scale data collection efforts to help us chart out new mechanisms that affect lysis.

Lastly, I’m excited to combine ideas from this (and similar) papers to the idea of deep model predictive control — the notion that we can use a machine learning model that can predict the outcomes of phage/host/antibiotic combinations to “direct” the evolution based on recommendations from the model, like in this paper, where they directed gene expression via an optogenetic system.

~ Jan

Access: https://doi.org/10.1128/mbio.00504-24

Al-Anany, A. M., Fatima, R., Nair, G., Mayol, J. T., & Hynes, A. P. (2024). Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny. In V. Sperandio & A. Maresso (Eds.), mBio. American Society for Microbiology. https://doi.org/10.1128/mbio.00504-24


I hope you enjoyed this month’s Picks! There’s too many cool papers coming out, especially at the intersection of phage, bioinformatics and machine learning (as you can see, I’m quite biased…). I’ll let Jess pick some papers next time…

See you next month!
~ Jan

Capsid & Tail

Follow Capsid & Tail, the periodical that reports the latest news from the phage therapy and research community.

We send Phage Alerts to the community when doctors require phages to treat their patient’s infections. If you need phages, please email us.

Sign up for Phage Alerts

In collaboration with

Mary Ann Liebert PHAGE

Supported by

Leona M. and Harry B. Helmsley Charitable Trust

Crossref Member Badge